sur Fresenius Medical Care AG & Co. KGaA (ETR:FME)
Fresenius Medical Care Accelerates Share Buyback Program
On January 9, 2026, Fresenius Medical Care AG announced the continuation of its share buyback program, which was initially disclosed on June 17, 2025. The company plans to buy back a second tranche of shares valued at approximately EUR 415 million, aiming to complete this phase by May 8, 2026. This action is a part of a broader program worth EUR 1 billion. The first tranche was finalized ahead of schedule by December 29, 2025.
The share buyback will take place on the stock exchange, with the primary goal of redeeming the shares and a smaller portion allocated for incentive-based compensation plans. This initiative is supported by an authorization from the company's Annual General Meeting held in May 2021.
R. H.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Fresenius Medical Care AG & Co. KGaA